Subsys
NDC Package 71500-012-15
Package Information
Subsys is indicated for the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving and who are tolerant to around-the-clock opioid therapy for their underlying persistent cancer pain.Patients considered opioid tolerant are those who are taking for one week or longer, around-the-clock medicine consisting of at least 60 mg of oral morphine per day, at least 25 mcg of transdermal fentanyl per hour, at least 30 mg of oral oxycodone per day, at least 8 mg of oral hydromorphone per day, or at least 25 mg oral oxymorphone per day, or at least 60mg oral hydrocodone per day, or an equianalgesic dose of another opioid daily for a week or longer. Marketed by West Therapeutics Development, Llc, this product is identified by NDC 71500-012 and is authorized under FDA application NDA202788.
Identification & Billing
- RxCUI: 1237050 - fentaNYL 100 MCG/ACTUAT Mucosal Spray
- RxCUI: 1237050 - fentanyl 0.1 MG/ACTUAT Mucosal Spray
- RxCUI: 1237050 - fentanyl 0.1 MG/ACTUAT Sublingual Spray
- RxCUI: 1237050 - fentanyl 100 MCG/ACTUAT Mucosal Spray
- RxCUI: 1237055 - Subsys 100 MCG/ACTUAT Mucosal Spray
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 71500 - West Therapeutics Development, Llc
- 71500-012 - Subsys
- 71500-012-15 - 15 BLISTER PACK in 1 CARTON / 2 BOTTLE, SPRAY in 1 BLISTER PACK / 1 SPRAY in 1 BOTTLE, SPRAY
- 71500-012 - Subsys
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 71500-012-15 identifies a specific commercial package of 15 blister pack in 1 carton / 2 bottle, spray in 1 blister pack / 1 spray in 1 bottle, spray of Subsys, labeled by West Therapeutics Development, Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by West Therapeutics Development, Llc on March 10, 2021. The current certification is valid through December 31, 2022.
How is this West Therapeutics Development, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 71500001215. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.